Skip to main content
Clinical Trials/NL-OMON48191
NL-OMON48191
Completed
Not Applicable

An exploratory, non-interventional study to biotype patients with facioscapulohumeral muscular dystrophy (FSHD) and controls using digital technologies - Digital biotyping of FSHD patients and controls.

Facio Therapies0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Facio Therapies
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Facio Therapies

Eligibility Criteria

Inclusion Criteria

  • \* FSHD patients:
  • Genetically confirmed FSHD.
  • Symptomatic, as demonstrated by Lamperti score \>0\.
  • Android\-based smartphone with Android version 5\.0 or higher.
  • Age 16\+ years.;\* Controls:
  • Unrelated subjects without FSHD.
  • Android\-based smartphone with Android version 5\.0 or higher.
  • Age 16\+ years.

Exclusion Criteria

  • \* FSHD patients:
  • Inability to give consent.
  • Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.;\* Controls:
  • Inability to give consent.
  • Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials